Fulvestrant in postmenopausal women with metastatic breast cancer progressing on prior endocrine therapy-updated results from an expanded access programme

被引：0

作者：

Petruzelka, L. ^{[1
]}

Zimovjanova, M. ^{[1
]}

Konopasek, B. ^{[1
]}

Mares, P. ^{[1
]}

Dlouha, Z. ^{[1
]}

机构：

[1] Charles Univ Prague, Fac Med 1, Dept Oncol, Prague, Czech Republic

来源：

ANNALS OF ONCOLOGY | 2004年 / 15卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：36 / 36

页数：1

共 50 条

[41] Palbociclib (PAL) in combination with fulvestrant (F) in pre-/peri-menopausal (PreM) women with metastatic breast cancer (MBC) and prior progression on endocrine therapy - results from Paloma-3. [J].

Loibl, Sibylle ;

Turner, Nicholas C. ;

Ro, Jungsil ;

Cristofanilli, Massimo ;

Iwata, Hiroji ;

Im, Seock-Ah ;

Masuda, Norikazu ;

Loi, Sherene ;

Andre, Fabrice ;

Harbeck, Nadia ;

Verma, Sunil ;

Folkerd, Elizabeth ;

Theall, Kathy Puyana ;

Zhang, Ke ;

Bartlett, Cynthia Huang ;

Dowsett, Mitch .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)

[42] Clinical activity of fulvestrant in metastatic breast cancer previously treated with endocrine therapy and/or chemotherapy [J].

Heo, Mi Hwa ;

Kim, Hee Kyung ;

Lee, Hansang ;

Kim, Ji-Yeon ;

Ahn, Jin-Seok ;

Im, Young-Hyuck ;

Park, Yeon Hee .

KOREAN JOURNAL OF INTERNAL MEDICINE, 2019, 34 (05) :1100-+

[43] Sequencing of hormonal therapy in postmenopausal women with metastatic breast cancer [J].

Parker, LM .

CLINICAL THERAPEUTICS, 2002, 24 :C43-C57

[44] Updated safety from a double-blind phase 3 trial (PALOMA-3) of fulvestrant with placebo or with palbociclib in pre- and postmenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer that progressed on prior endocrine therapy [J].

Verma, S. ;

DeMichele, A. M. ;

Loi, S. ;

Ro, J. ;

Colleoni, M. ;

Iwata, H. ;

Harbeck, N. ;

Stearns, V. ;

Cristofanilli, M. ;

Bartlett, C. Huang ;

Schnell, P. ;

Zhang, K. ;

Thiele, A. ;

Turner, N. C. ;

Rugo, H. S. .

CANCER RESEARCH, 2016, 76

[45] First results from the PACT programme (patient's anastrozole compliance to therapy programme) evaluating the compliance of postmenopausal women with early breast cancer to endocrine adjuvant therapy and the impact of a standardised information service [J].

Runnebaum, I. B. ;

Stickeler, E. ;

Baier, B. ;

Hadji, P. ;

Jackisch, C. ;

Harbeck, N. ;

Blettner, M. ;

Lueck, H.-J. ;

Zaun, S. ;

Martin, R-R ;

Schmitt, D. ;

Schulte, H. ;

von Fircks, A. Rexrodt ;

Haidinger, R. ;

Kreienberg, R. .

ONKOLOGIE, 2010, 33 :29-30

[46] Adjuvant therapy for postmenopausal women with endocrine-sensitive breast cancer [J].

Freedman, Rachel A. ;

Winer, Eric P. .

BREAST, 2010, 19 (02) :69-75

[47] Adjuvant endocrine therapy for breast cancer: Giving postmenopausal women a voice [J].

Vandezande, L. ;

Reymen, M. ;

Raeymaekers, B. ;

Heedfeld, I. ;

Biebuyck, D. ;

Christiaens, M. R. ;

Neven, P. .

EUROPEAN JOURNAL OF CANCER, 2016, 57 :S30-S30

[48] ECONOMIC EVALUATION OF FULVESTRANT 500MG FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST CANCER WHO HAVE PROGRESSED ON ENDOCRINE THERAPY [J].

Polanco, A. C. ;

Salazar, A. ;

Soto, H. ;

Pizarro, M. .

VALUE IN HEALTH, 2014, 17 (03) :A87-A87

[49] Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice [J].

Blancas, I. ;

Fontanillas, M. ;

Conde, V. ;

Lao, J. ;

Martinez, E. ;

Sotelo, M. J. ;

Jaen, A. ;

Bayo, J. L. ;

Carabantes, F. ;

Illarramendi, J. J. ;

Gordon, M. M. ;

Cruz, J. ;

Garcia-Palomo, A. ;

Mendiola, C. ;

Perez-Ruiz, E. ;

Bofill, J. S. ;

Baena-Canada, J. M. ;

Janez, N. M. ;

Esquerdo, G. ;

Ruiz-Borrego, M. .

CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (07) :862-869

[50] Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice [J].

I. Blancas ;

M. Fontanillas ;

V. Conde ;

J. Lao ;

E. Martínez ;

M. J. Sotelo ;

A. Jaen ;

J. L. Bayo ;

F. Carabantes ;

J. J. Illarramendi ;

M. M. Gordon ;

J. Cruz ;

A. García-Palomo ;

C. Mendiola ;

E. Pérez-Ruiz ;

J. S. Bofill ;

J. M. Baena-Cañada ;

N. M. Jáñez ;

G. Esquerdo ;

M. Ruiz-Borrego .

Clinical and Translational Oncology, 2018, 20 :862-869

← 1 2 3 4 5 →